FDA Inspection 1171804 — Vitalant
The FDA completed an inspection of Vitalant on Jun 6, 2022 in Lake Bluff, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 6, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Lake Bluff, IL (United States)